维普中文期刊产品整合服务
34篇 您的检索式:作者名="Mulder HJ"
    题名 作者 年代 出处 被引量
1On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprineor 6-mercaptopurine intolerant IBD patients显示文摘AIM: To determine the tolerability and safety profile of a low-dose maintenance therapy with 6-TG in azathioprine (AZA) or 6-mercaptopurine (6-MP) intolerant inflammatory bowel disease (IBD) patients over a treatment period of at least 1 year.METHODS: Database analysis.RESULTS: Twenty out of ninety-five (21%) patients discontinued 6-TG (mean dose 24.6 mg; mean 6-TGN level 540 pmol/8×108 RBC) within 1 year. Reasons for discontinuation were GI complaints (31%), malaise (15%)and hepatotoxicity (15%). Hematological events occurred in three patients, one discontinued treatment. In the 6-TG-tolerant group, 9% (7/75) could be classified as hepatotoxicity. An abdominal ultrasound was performed in 54% of patients, one patient had splenomegaly.CONCLUSION: The majority of AZA or 6-MP-intolerant IBD patients (79%) is able to tolerate maintenance treatment with 6-TG (dosages between 0.3 and 0.4 mg/kg per d). 6-TG may still be considered as an escape maintenance immunosuppressant in this difficult to treat group of patients, taking into account potential toxicity and efficacy of other alternatives. The recently reported hepatotoxicity is worrisome and 6-TG should therefore be administered only in prospective trials.Nanne KH de Boer Luc JJ Derijks Lennard PL Gilissen Daniel W Hommes Leopold GJB Engels Sybrand Y de Boer Gijsbertus den Hartog Piet M Hooymans Anja BU M(?)kelburg Barend D Westerveld Anton HJ Naber Chris JJ Mulder Dirk J de Jong 2005World Journal of Gastroenterology2005,11,35:4
2Anterior mediastinal presentation of a gianl angiomyolipoma显示文摘Amir AM Zeebregts CJ Mulder HJ 2004Ann Thorac Surg2004,78,6:1
3Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty(REGRESS trial)显示文摘Mulder HJ Bal ET Jukema JW Zwinderman AH Schalij MJ van Boven AJ 2000Am J Cardiol2000,86,7:1
4Improvement of tidal breathing pattern analysis in children with asthma by on-line automatic data processing显示文摘Van der Ent CK Brackel HJ Mulder P 1996European Respiratory Journal1996,9,6:1
5Association of polymorphism in the cytochrome CYP2D6 and the efficacy and tolerability of simvastatin 显示文摘Mulder AB Van Lijf HJ Bon MA 2001Clin Pharmacol Ther2001,0,6:1
6Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty ( REGRESS trial) 显示文摘Mulder HJ Bal ET Jukema JW 2000Am J Cardiol2000,86,7:1
7Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial) 显示文摘Mulder HJ Bal ET Jukema JW 2000Am J Cardiol2000,86,:1
8Association of polymorphism in the cytochrome CYP2D6 and the efficacy and tolerabihty of simvastatin显示文摘Mulder AB Van Lijf HJ Bon MA 2001Clin Pharmacol Ther2001,70,6:1
9Association of polymorphism in the cytochrome CYP2D6 and the efficacy and tolerability of simvastatin 显示文摘MULDER AB V AN LIJF HJ BON MA 2001Clin Pharmacol Ther2001,70,6:1
10Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial) 显示文摘Mulder HJ Bal ET Jukema JW 2000Am J Cardiol2000,86,7:1
11Improvement of tidal breathing pattern analysis in children with asthma by on-line automatic data processing 显示文摘van der Ent CK Brackel HJ Mulder P 1996Eur Respir J1996,9,6:1
12Anterior mediastinal presentation of a giant angiomyolipoma显示文摘Amir AM Zeebregts CJ Mulder HJ 2004Ann Thorae Surg2004,78,6:1
13Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial) 显示文摘Mulder HJ Bal ET Jukema JW 2000Am J Cardiol2000,86,7:1
14Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial)显示文摘Mulder HJ Bal ET 2000Am J Cardiol2000,86,:1
15In vitro adhesion to enamel and in vivo colonization of tooth surfaces by lactobacilli from a bio-yoghurt显示文摘Busscher HJ Mulder A van der Mei HC 1999Caries Res1999,33,5:1
16Association of polymorphism in the cytochrome CYP2D6 and the efficacy and to lerability of simvastatin 显示文摘Mulder AB Van HJ Bon M 2001Clin Pharmacal Ther2001,70,:1
17Changes in Farr radioimmunoassay and EllA fluorescence immunoassay anti- dsDNA in relation to exacerbation of SLE显示文摘Hillebrand JJ Moens HJ Mulder AH 2013Lupus2013,22,11:1
18Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty(REGRESS trial)显示文摘Mulder HJ Bal ET Jukema JW 2000Am J Cardiol2000,86,7:1
19Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial)显示文摘Mulder HJ Bal ET Jukema JW 2000Am J Cardiol2000,86,7:1
20Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial)显示文摘Mulder HJ Bal ET 2000Am J Cardiol2000,86,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费